← Every company
BioCryst Pharmaceuticals Inc SEC Filings
What BioCryst Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
BCRX overview →Filings on file
154
since Sep 26, 2016
Warning signs
0
none filed
Last results
Aug 5, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
None of these
BioCryst Pharmaceuticals Inc has filed nothing of this kind in the history kept here.
Source: BioCryst Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on BCRX
Company overviewEverything on BCRX in one place, with the price.Insider tradingWhat BCRX's own officers and directors buy and sell.Executive payWhat BCRX awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in BCRX.Funds holding itWhich funds and ETFs hold BCRX, and how big a bet.Federal contractsWhat federal agencies pay BCRX.PatentsWhat BCRX is filing at the patent office.